Vincent Tam
Professor of Pharmacy Practice and Translational Research
Department of Pharmacy Practice and Translational Research
Professor of Pharmaceutics (Joint Appointment)
Department of Pharmacological and Pharmaceutical Sciences
Office
University of Houston College of Pharmacy
Health 2, Room 4041
4349 Martin Luther King Boulevard
Houston, TX 77204-5039
Contact
vtam@uh.edu - 832-842-8316
Dr. Vincent Tam is a leading translational researcher in antimicrobial therapeutics, committed to advancing patient care through innovative and scientifically rigorous solutions to combat antimicrobial resistance. His work focuses on improving the standard of care by developing next-generation therapies designed to outpace evolving resistance mechanisms. Dr. Tam’s research stands at the intersection of clinical relevance and scientific innovation, positioning him as a top-tier contributor in the fight against global AMR.
Antimicrobial resistance is not a distant threat—it is a present, growing crisis impacting patient care today. Our team is leading an NIH-funded project focused on developing personalized antimicrobial therapies—a collaborative effort with clinical partners at one of the leading hospitals in the Texas Medical Center. By integrating pharmacokinetics, microbiology, and patient-specific data, we aim to optimize treatment strategies for drug-resistant infections in real-world settings. This work represents a critical step toward precision medicine in infectious diseases—and a model for how translational research can directly enhance patient care.
Research Interests
Pharmacokinetics and Pharmacodynamics of antimicrobials, Mathematical modeling and simulation of biological processes, Mechanisms of bacterial resistance
- B.Sc. (Pharm), National University of Singapore, Singapore
- Pharm.D., Albany College of Pharmacy, Albany, N.Y.
- Board Certified Infectious Diseases Pharmacist (BCIDP), Board of Pharmacy Specialties
- Galgat H, Pouya N, Tam VH, Nikolaou M. Using machine learning to design effective antimicrobial dosing regimens. Comput Chem Eng 2026; 210: 109645
- Pouya N, Finch NA, Granillo A, Bhimraj A, Tam VH, Miller WR. Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of 2 cases. Antimicrob Agents Chemother 2025; 69(11): e0067425
- Hudson CS, Smith JE, Sun R, Vuong LT, Truong LD, Sheikh-Hamad D, M Nigo, Hu M, Tam VH. Exploration of zileuton protective mechanisms against vancomycin-associated nephrotoxicity. Toxicol Appl Pharmacol 2025; 505: 117543
- Hudson CS, Xiao Y, Tam VH, Truong LD. Protection against vancomycin-associated nephrotoxicity by zileuton: role of mitochondria revealed by electron microscopic study. Ultrastruct Pathol 2025; 49(5): 414-20
- Barua S, Smith JE, Tam VH, Nikolaou M. Enhancing the time-to-positivity paradigm for guidance of antimicrobial therapy: a model-based approach. Comput Chem Eng 2025; 203: 109325
- Eales BM, Smith JE, Pouya N, Hudson CS, Baptista RP, Tran TT, Tam VH. Impact of iron limitation on in vitro and in vivo activity of ceftazidime against A. baumannii. Diagn Microbiol Infect Dis 2025; 113(3): 116991
Awards
- Fellow, American Academy of Microbiology/American Society for Microbiology, 2026
- Excellence in Research, Scholarship and Creative Activity-Professor Level, University of Houston, 2024-25
- Fellow, Society of Infectious Diseases Pharmacists, 2024
- American College of Clinical Pharmacy Therapeutic Frontiers Lecture Award, 2024
- American Society of Health-System Pharmacists (ASHP) Foundation Literature Award for Sustained Contributions, 2019
- Fellow, Infectious Diseases Society of America, 2018
- Pharmacotherapy Paper of the Year Award, Society of Infectious Diseases Pharmacists, 2014
- American Society of Health-System Pharmacists Best Practices Award, Team Member, Center for Antimicrobial Stewardship and Epidemiology at St. Luke's Episcopal Hospital, 2010
- University of Houston Excellence in Research and Scholarship Award, University of Houston, 2008
- Best Poster Award, Sixth International Symposium on Antimicrobial Agents and Resistance, 2007
- Young Investigator Award, Society of Infectious Diseases Pharmacists, 2006
- Young Investigator Award, American College of Clinical Pharmacy, 2006
- Resident of the Year, Southeastern Michigan Society of Health-System Pharmacists, 2000
Medica Coverage
- 2026 ASM Fellow Designation
- UH News Release: Outsmarting Superbugs Resistant to Antibiotics
- 2024 SIDP Fellow Designation
- 2024 ACCP Therapeutic Frontiers Lecture Award
- 2019 Literature Award for Sustained Contributions
- UH News Release: A New Take on Fighting Multi-Drug Resistant Bacteria
- UH News Release: UH Team Fights Antibiotic Resistance with NIH Grant
- HoustonPBS UH Moment: Better Antibiotics, Faster & Cheaper